InsidersTradesSigma
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
11
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Maggiore Christopher D., Director. Insider active across 1 company, notably Zivo Bioscience, Inc.. In total, 15 filings have been logged. Split: 11 buys · 1 sell. Total volume traded: €1.3m. Activity tracked since 2 June 2021. The latest transaction was filed on 14 January 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Maggiore Christopher D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
1,766 shares@ US$8.491.0% of flowCommon StockSEC:0001654954-26-000631:0
Canonical exit: 14 Apr 2026 (T+90)
23,682 shares@ US$12.0119.2% of flowCommon StockSEC:0001654954-25-011614:0
Canonical exit: 6 Jan 2026 (T+90)
20 shares@ US$16.250.0% of flowCommon StockSEC:0001654954-25-004085:0
1,300 shares0Common StockSEC:0001654954-25-000105:0
31,336 shares@ US$8.3416.2% of flowCommon StockSEC:0001654954-24-011071:0
Canonical exit: 20 Nov 2024 (T+90)
2,080 shares@ US$8.051.1% of flowCommon StockSEC:0001654954-24-009647:0
Canonical exit: 24 Oct 2024 (T+90)
6,273 shares0Common StockSEC:0001654954-24-007745:0
36,630 sharesCommon StockSEC:0001654954-24-007464:0
157,692 shares@ US$1.3012.7% of flowCommon StockSEC:0001654954-24-000086:0
Canonical exit: 28 Mar 2024 (T+90)
45,000 shares@ US$1.002.9% of flowCommon StockSEC:0001654954-23-015555:0
Canonical exit: 12 Mar 2024 (T+90)
5,200 shares@ US$3.52811.3% of flowCommon StockSEC:0001654954-23-001647:0
Canonical exit: 13 Dec 2022 (T+90)
5,200 shares@ US$3.52811.3% of flowCommon StockSEC:0001654954-22-012673:0
Canonical exit: 13 Dec 2022 (T+90)
28,363 shares@ US$3.55027.0% of flowCommon StockSEC:0001654954-22-001719:0
Canonical exit: 10 May 2022 (T+90)
7,560 shares@ US$2.63971.4% of flowCommon StockSEC:0001654954-22-000532:0
Canonical exit: 11 Apr 2022 (T+90)
100,000 shares@ US$4.9932.2% of flowCommon StockSEC:0001078782-21-000534:0
Canonical exit: 31 Aug 2021 (T+90)
15 of 15 declarations
About Maggiore Christopher D.
Maggiore Christopher D. is Administrateur at Zivo Bioscience, Inc. (XNAS). He has 15 filings in total, and among the sampled recent filings the transactions are predominantly acquisitions, with EUR 1286006 in buys and EUR 296 in sells, over the period from 2021-06-04 to 2026-01-27.
